OABI
OmniAb Inc.
NASDAQ: OABI · HEALTHCARE · BIOTECHNOLOGY
$1.36
-2.86% today
Updated 2026-04-29
Market cap
$208.49M
P/E ratio
—
P/S ratio
11.17x
EPS (TTM)
$-0.57
Dividend yield
—
52W range
$1 – $2
Volume
0.4M
OmniAb Inc. (OABI) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $-5.20M | $3.62M | $-5.67M | $-3.59M | $2.35M | $-39.66M | $-36.45M |
| Capital expenditures | $255000.00 | $1.75M | $4.07M | $17.17M | $1.64M | $1.88M | $565000.00 |
| Depreciation | — | — | — | — | — | — | — |
| Stock-based comp | $6.66M | $9.16M | $15.06M | $18.32M | $24.82M | $21.50M | $15.82M |
| Free cash flow | $-5.45M | $1.87M | $-9.74M | $-20.75M | $703000.00 | $-41.54M | $-37.02M |
| Investing cash flow | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — |